Yizhen Dong

Yizhen was a Healthcare & Life Sciences Growth Equity Leader at Koch Disruptive Technologies, a former Partner at Global Founders Capital, and was earlier a Principal at 11.2 Capital, working in the frontier of computational biology and synthetic biology. He holds an MBA (full-tuition scholar) from The University of Chicago Booth School of Business, a Master’s in Computational Biology from the University of Maryland, and a BA in Economics from Vanderbilt University.

Key Experience

Investment Roles

• Koch Disruptive Technologies, Growth Equity Lead

• Global Founders Capital, Partner

Education

• MBA, University of Chicago Booth School of Business

• MA. Computational Biology, University of Maryland

• BA, Economics, Vanderbilt University

Investment Partner